< News, Press, & Events

Press Release

Genomenon Announces Participation in BIO Partnering™ @JPM Week 2026

FOR IMMEDIATE RELEASE

January 8, 2026 Ann Arbor, MI

Genomenon Announces Participation in BIO Partnering™ @JPM Week 2026

Executive Team to share how literature-based Real-World Evidence (RWE) deepens the company’s role as a partner of choice for pharma companies that are developing therapies for rare diseases

Ann Arbor, Michigan – January 8, 2024 –Genomenon, Inc., a genomic intelligence company, announced that it will be participating in BIO Partnering™ @JPM Week 2026, which takes place from January 12th to January 15th in San Francisco, California.

Details of the event are as follows:

Event: BIO Partnering @JPM Week
Date: January 12-15, 2026
Registration:
https://www.bio.org/events/bio-partnering-jpm/registration

Genomenon executives will be available to conduct one-on-one meetings with registered pharmaceutical companies and investors. They are looking to raise awareness within cancer and genetic disease therapeutics regarding the hidden costs caused by a lack of access to comprehensive genomic information at every phase of a drug program. 

Schedule your meeting with the Genomenon’s leadership team by connecting with one of our team members through the BIO Partnering system.

About
Genomenon

Genomenon is a real-world evidence and genomics intelligence company supporting pharmaceutical organizations to accelerate drug development efforts in rare indications and precision oncology. Our solutions transform biomedical literature into structured, evidence-based patient and variant landscapes that help enhance disease understanding, guide trial design and support label expansion. The Genomenon team empowers pharma to make more confident, data-driven decisions that meaningfully influence drug development strategy.

About
BIO

BIO is the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the U.S. and in more than 30 other nations.

BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.

For more information, visit www.bio.org

Read the Article
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.